Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Tipiracil Hydrochloride; Trifluridine Patent Expiration

Tipiracil Hydrochloride; Trifluridine is Used for treating metastatic colorectal cancer in patients previously treated with specific chemotherapy combinations. It was first introduced by Taiho Oncology Inc in its drug Lonsurf on Sep 22, 2015. 2 different companies have introduced drugs containing Tipiracil Hydrochloride; Trifluridine.


Tipiracil Hydrochloride; Trifluridine Patents

Given below is the list of patents protecting Tipiracil Hydrochloride; Trifluridine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lonsurf US10456399 Method for treating cancer patients with severe renal impairment Feb 03, 2037 Taiho Oncology
Lonsurf US10457666 Stable crystal form of tipiracil hydrochloride and crystallization method for the same Jun 17, 2034 Taiho Oncology
Lonsurf US10960004 Method for treating cancer patients with severe renal impairment Feb 03, 2037 Taiho Oncology
Lonsurf US5744475 Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same Mar 28, 2016

(Expired)

 Taiho Oncology
Lonsurf US6479500 Agents for alleviating side effects Mar 16, 2020

(Expired)

 Taiho Oncology
Lonsurf US7799783 Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor Dec 16, 2026 Taiho Oncology
Lonsurf US9527833 Stable crystal form of tipiracil hydrochloride and crystallization method for the same Jun 17, 2034 Taiho Oncology
Lonsurf US9943537 Antitumor agent and antitumor effect enhancer Sep 05, 2034 Taiho Oncology
Lonsurf USRE46284 Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor Sep 22, 2029 Taiho Oncology


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Tipiracil Hydrochloride; Trifluridine Generics

Several generic applications have been filed for Tipiracil Hydrochloride; Trifluridine.

Given below is the list of companies who have filed for Tipiracil Hydrochloride; Trifluridine generic.


1. NATCO

Natco Pharma Ltd has filed for 2 different strengths of generic version for Tipiracil Hydrochloride; Trifluridine. All of these versions come by the name TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE. Given below are the details of the strengths of this generic introduced by Natco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6.14MG BASE; 15MG tablet Prescription ORAL AB Jun 13, 2023
EQ 8.19MG BASE; 20MG tablet Prescription ORAL AB Jun 13, 2023